Siren »

Confluent shares owned by Siren

Quarter-by-quarter ownership of Confluent (CFLT) shares owned by Siren from 13F filings

Historical chart of Siren investment in Confluent

Tip: Access up to 7 years of quarterly data

All positions including Confluent held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Confluent by Siren

Quarter filed Position value Share count Share price at filing
2025-09-30 $743k 38k 19.80

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Disc Medicine (IRON)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Avidity Biosciences Ord (RNA)
Stoke Therapeutics (STOK)
Lexicon Pharmaceuticals Com New (LXRX)
Rhythm Pharmaceuticals (RYTM)

View all positions for Siren

Top funds holding Confluent

Vanguard Group
BlackRock
Point72 Asset Management
Altimeter Capital Management
Champlain Investment Partners
William Blair Investment Management
Jericho Capital Asset Management
Citadel Advisors
Optimus Prime Fund Management
Cadian Capital Management
Millennium Management
Geode Capital Management
D. E. Shaw & Co
Franklin Resources
Pictet Asset Management Holding SA

View all funds holding Confluent